FY2024 EPS Estimates for KORU Medical Systems, Inc. Reduced by B. Riley (NASDAQ:KRMD)

KORU Medical Systems, Inc. (NASDAQ:KRMD) – Analysts at B. Riley lowered their FY2024 earnings estimates for shares of KORU Medical Systems in a note issued to investors on Wednesday, May 1st. B. Riley analyst W. Wood now anticipates that the company will post earnings per share of ($0.16) for the year, down from their previous forecast of ($0.15). B. Riley currently has a “Buy” rating and a $4.00 target price on the stock. The consensus estimate for KORU Medical Systems’ current full-year earnings is ($0.16) per share.

KORU Medical Systems Price Performance

Shares of NASDAQ KRMD opened at $2.26 on Monday. KORU Medical Systems has a fifty-two week low of $1.98 and a fifty-two week high of $4.30. The stock has a market capitalization of $103.42 million, a price-to-earnings ratio of -8.07 and a beta of 0.55. The company has a debt-to-equity ratio of 0.02, a current ratio of 4.01 and a quick ratio of 3.37. The business has a 50-day moving average of $2.21 and a 200-day moving average of $2.23.

KORU Medical Systems (NASDAQ:KRMD) last issued its quarterly earnings results on Wednesday, May 1st. The company reported ($0.02) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.04) by $0.02. KORU Medical Systems had a negative net margin of 45.24% and a negative return on equity of 25.10%. The firm had revenue of $8.20 million for the quarter, compared to analyst estimates of $7.49 million. During the same period in the previous year, the business earned ($0.05) EPS.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of KRMD. Mesirow Financial Investment Management Inc. bought a new position in shares of KORU Medical Systems in the first quarter valued at $26,000. Advisor Resource Council acquired a new stake in KORU Medical Systems in the first quarter valued at $63,000. Bard Associates Inc. grew its position in shares of KORU Medical Systems by 22.5% in the 4th quarter. Bard Associates Inc. now owns 26,710 shares of the company’s stock valued at $66,000 after acquiring an additional 4,910 shares during the period. Meros Investment Management LP raised its holdings in shares of KORU Medical Systems by 12.3% in the 3rd quarter. Meros Investment Management LP now owns 515,396 shares of the company’s stock valued at $1,392,000 after purchasing an additional 56,293 shares during the period. Finally, B. Riley Asset Management LLC lifted its stake in KORU Medical Systems by 2.7% in the 3rd quarter. B. Riley Asset Management LLC now owns 833,663 shares of the company’s stock valued at $2,251,000 after purchasing an additional 21,738 shares during the last quarter. 58.60% of the stock is currently owned by institutional investors.

About KORU Medical Systems

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.